Atlas Trials

ctDNA Detection of MRD in Predicting Postoperative Recurrence in Biliary Tract Cancers:A Multicenter Prospective Trial

Clinical trial NCT05743959 · UNKNOWN

Trial details

NCT number
NCT05743959
Sponsor
The First Affiliated Hospital with Nanjing Medical University
Status
UNKNOWN
Study type
OBSERVATIONAL
Biliary Tract Cancer
Start date
2022-05-01
Primary completion
2024-12-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.